DSpace@İnönü

Selective endothelin a ETA receptor antagonist BQ 123 reduces both myocardial infarct size and oxidant injury

Basit öğe kaydını göster

dc.contributor.author Özdemir, Ramazan
dc.contributor.author Parlakpınar, Hakan
dc.contributor.author Polat, Alaadin
dc.contributor.author Çolak, Cemil
dc.contributor.author Ermiş, Necip
dc.contributor.author Acet, Ahmet
dc.date.accessioned 2018-01-12T06:43:30Z
dc.date.available 2018-01-12T06:43:30Z
dc.date.issued 2006
dc.identifier.citation Özdemir, R., Parlakpınar, H., Polat, A., Çolak, C., Ermiş, N., & Acet, H. A. (2006). Selective Endothelin A Eta Receptor Antagonist Bq 123 Reduces Both Myocardial İnfarct Size And Oxidant İnjury. Toxicology, 219(1–3), 142–149. tr_TR
dc.identifier.uri https://ac.els-cdn.com/S0300483X05005597/1-s2.0-S0300483X05005597-main.pdf?_tid=e00295a8-f762-11e7-9719-00000aacb35e&acdnat=1515739158_c1b917b4a7e91ee1c4f83f3d2556f729
dc.identifier.uri http://hdl.handle.net/11616/7978
dc.description Toxicology 219 (2006) 142–149. tr_TR
dc.description.abstract Objective: Endothelins (ET) can be considered stress-responsive regulators working in paracrine and autocrine fashion. It has been suggested that elevated levels of ET may be responsible for the low coronary re-flow phenomena. Ischemia–reperfusion (I/R) was shown to stimulate ET release in rat heart; however, the mechanism(s) of this effect has not been clarified. Therefore, this study was focused to investigate the effect of BQ-123, selective ETA receptor antagonist, on three aspects of myocardial ischemia–reperfusion (MI/R) injury: hemodynamic parameters, infarct size and oxidant–antioxidant status in the absence and presence of ET-1 in an vivo rat model. Methods and results: To produce MI/R, a branch of the descending left coronary artery was occluded for 30 min followed by 2 h reperfusion. ECG changes, blood pressure (BP), and heart rate (HR) were measured before occlusion and continued both occlusion and reperfusion. Forty rats were randomly assigned to five groups equally: (1) sham-operated rats without coronary ligation, (2) I/R group, (3) I/R + BQ-123-treated group (10 g/kg/min i.v.), (4) I/R + ET-treated group (25 ng/kg/min i.v.), (5) I/R + ET + BQ123-treated group. The results are expressed as mean ± S.E.M. In the ET-1 plus I/R group, the ratio between the infarcted area and area at risk 56 ± 1% was significantly higher than I/R group (49 ± 1%). In the BQ-123 group with or without exogenous ET-1 treatment in I/R group, this ratio was significantly lower at 40 ± 2 and 37 ± 1%, respectively. As compared to sham group, I/R increased lipid peroxidation whereas decreased nitric oxide (NO), glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) contents. This decreased antioxidant enzymatic defense could result in aggravated oxidative damage in I/R group rat hearts. ET-1 administration group showed severe oxidative damage. BQ-123 administrations to I/R group with or without ET-1 caused significantly decrease in lipid peroxidation and increased in SOD, CAT activities and NO generation and GSH content when compared with I/R group alone. Conclusions: The most important finding of the present study is that the ET blockade reduced I/R-induced myocardial injury. The mechanism of this reduction was speculated to be a resistance to ischemic injury in the subcellular levels of the myocardium conferred by a reduction of vascular constriction and improvement of imbalance in the antioxidant status. © 2005 Elsevier Ireland Ltd. All rights reserved. tr_TR
dc.language.iso eng tr_TR
dc.publisher Toxicology tr_TR
dc.rights info:eu-repo/semantics/openAccess tr_TR
dc.subject ETA receptor antagonist (BQ-123) tr_TR
dc.subject Endothelin tr_TR
dc.subject Reactive oxygen radicals tr_TR
dc.subject Rat tr_TR
dc.title Selective endothelin a ETA receptor antagonist BQ 123 reduces both myocardial infarct size and oxidant injury tr_TR
dc.type article tr_TR
dc.relation.journal Toxicology tr_TR
dc.contributor.department İnönü Üniversitesi tr_TR
dc.contributor.authorID 58684 tr_TR
dc.contributor.authorID 102000 tr_TR
dc.contributor.authorID 100549 tr_TR
dc.contributor.authorID 9712 tr_TR
dc.contributor.authorID 120232 tr_TR
dc.identifier.volume 129 tr_TR
dc.identifier.issue (1-3) tr_TR
dc.identifier.startpage 142 tr_TR
dc.identifier.endpage 149 tr_TR


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster